Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

Overview of attention for article published in PLOS ONE, February 2008

Altmetric Badge

Mentioned by

patent: 6 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 143 Dimensions

Readers on

mendeley: 55 Mendeley
connotea: 1 Connotea

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Influenza virus hemagglutinin proteins and uses thereof

Grant US-11865173-B2

United States of America

09 Jan 2024

Influenza virus hemagglutinin proteins and uses thereof

Grant US-11266734-B2

United States of America

08 Mar 2022

Anti-influenza B virus neuraminidase antibodies and uses thereof

Grant US-11254733-B2

United States of America

22 Feb 2022

Influenza virus vaccines and uses thereof

Grant US-10583188-B2

United States of America

10 Mar 2020

INFLUENZA VACCINE

Grant EP-2043682-B1

European Patent Office

02 Apr 2014

MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND…

Application WO-2010138564-A1

World Intellectual Property Organisation (WIPO)

02 Dec 2010

PLOS

Article Metrics

Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

Mentioned by

Citations

Readers on

Influenza virus hemagglutinin proteins and uses thereof

Grant US-11865173-B2

United States of America

Influenza virus hemagglutinin proteins and uses thereof

Grant US-11266734-B2

United States of America

Anti-influenza B virus neuraminidase antibodies and uses thereof

Grant US-11254733-B2

United States of America

Influenza virus vaccines and uses thereof

Grant US-10583188-B2

United States of America

INFLUENZA VACCINE

Grant EP-2043682-B1

European Patent Office

MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND…

Application WO-2010138564-A1

World Intellectual Property Organisation (WIPO)